Xylem Inc. (XYL) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Xylem’s revenue went from $3.8B in fiscal 2016 to $9.0B in fiscal 2025, growth of about 10.2% a year.
Net income in fiscal 2025 was $957M, a net margin of 10.6%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $9.1B and net income $1.1B.
Free cash flow was $910M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 36% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.1B | $9.0B | $8.6B | $7.4B | $5.5B | $5.2B | $4.9B | $5.2B | $5.2B | $4.7B | $3.8B |
| Gross profit | $3.6B | $3.5B | $3.2B | $2.7B | $2.1B | $2.0B | $1.8B | $2.0B | $2.0B | $1.8B | $1.5B |
| Operating income | $1.4B | $1.2B | $1.0B | $652M | $622M | $585M | $367M | $486M | $654M | $552M | $408M |
| Net income | $1.1B | $957M | $890M | $609M | $355M | $427M | $254M | $401M | $549M | $331M | $260M |
| EPS (diluted) | $4.52 | $3.92 | $3.65 | $2.79 | $1.96 | $2.35 | $1.40 | $2.21 | $3.03 | $1.83 | $1.45 |
| R&D | $231M | $226M | $230M | $232M | $206M | $204M | $187M | $191M | $189M | $181M | $110M |
| Revenue growth | — | +5.5% | +16.3% | +33.4% | +6.3% | +6.5% | −7.1% | +0.8% | +10.6% | +24.8% | +3.2% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.3B | $1.2B | $1.3B | $837M | $596M | $538M | $824M | $839M | $586M | $686M | $497M |
| Capital spending | -$351M | -$331M | -$321M | -$271M | -$208M | -$208M | -$183M | -$226M | -$237M | -$170M | -$124M |
| Free cash flow | $921M | $910M | $942M | $566M | $388M | $330M | $641M | $613M | $349M | $516M | $373M |
| Dividends paid | $405M | $391M | $350M | $299M | $217M | $203M | $188M | $174M | $152M | $130M | $112M |
| Buybacks | $1.6B | $15M | $20M | $25M | $52M | $68M | $61M | $40M | $59M | $25M | $4M |
| Stock-based pay | $55M | $53M | $56M | $60M | $37M | $33M | $26M | $29M | $30M | $21M | $18M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $1.5B | $1.1B | $1.0B | $944M | $1.3B | $1.9B | $724M | $296M | $414M | $308M |
| Debt | — | $2.4B | $2.3B | $2.6B | $2.2B | $2.7B | $3.4B | $2.6B | $2.3B | $2.2B | $2.4B |
| Equity | — | $11.5B | $10.6B | $10.2B | $3.5B | $3.2B | $3.0B | $3.0B | $2.8B | $2.5B | $2.2B |
| Total assets | — | $17.6B | $16.5B | $16.1B | $8.0B | $8.3B | $8.8B | $7.7B | $7.2B | $6.9B | $6.5B |
| Shares (diluted) | 233M | 244M | 244M | 218M | 181M | 182M | 181M | 181M | 181M | 181M | 180M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 39.8% | 38.5% | 37.5% | 36.9% | 37.7% | 38.0% | 37.5% | 39.0% | 38.9% | 39.2% | 38.8% |
| Operating margin | 15.1% | 13.5% | 11.8% | 8.8% | 11.3% | 11.3% | 7.5% | 9.3% | 12.6% | 11.7% | 10.8% |
| Net margin | 11.9% | 10.6% | 10.4% | 8.3% | 6.4% | 8.2% | 5.2% | 7.6% | 10.5% | 7.0% | 6.9% |
| FCF margin | 10.2% | 10.1% | 11.0% | 7.7% | 7.0% | 6.3% | 13.2% | 11.7% | 6.7% | 11.0% | 9.9% |
| ROIC | — | 7.1% | 6.4% | 4.9% | 8.9% | 8.2% | 5.2% | 8.5% | 12.1% | 8.3% | 6.9% |
| ROE | — | 8.3% | 8.4% | 6.0% | 10.2% | 13.3% | 8.6% | 13.6% | 19.8% | 13.2% | 11.9% |
Frequently asked questions
What is Xylem’s annual revenue?
$9.0B in fiscal 2025 and $9.1B over the twelve months to September 30, 2026.
How much profit does Xylem make?
Net income was $957M in fiscal 2025 (net margin 10.6%).
Is Xylem’s revenue growing?
Yes: revenue rose 5.5% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.